Success Metrics

Clinical Success Rate
80.0%

Based on 8 completed trials

Completion Rate
80%(8/10)
Active Trials
3(20%)
Results Posted
13%(1 trials)
Terminated
2(13%)

Phase Distribution

Ph not_applicable
11
73%
Ph phase_2
1
7%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
1(8.3%)
N/ANon-phased studies
11(91.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

8 of 10 finished

Non-Completion Rate

20.0%

2 ended early

Currently Active

3

trials recruiting

Total Trials

15

all time

Status Distribution
Active(4)
Completed(8)
Terminated(2)
Other(1)

Detailed Status

Completed8
Recruiting3
Terminated2
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
3
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (8.3%)
N/A11 (91.7%)

Trials by Status

completed853%
terminated213%
unknown17%
recruiting320%
not_yet_recruiting17%

Recent Activity

3 active trials
Showing 5 of 15
recruitingphase_2

Long-Term Outcomes Following HBOT

NCT07732374
not_yet_recruiting

Retrospective Analysis of CPET and Cognitive Tests of Healthy Individuals, Treated With 60 Treatment of HBOT

NCT07596641
completed

Triple-Modal Therapy in Early-Stage Femoral Head Osteonecrosis (TM-ONFH)

NCT07560163
recruitingnot_applicable

Effect of Hyperoxygenated Environment on Maximal Muscle Strength

NCT07558928
recruitingnot_applicable

Intermittent Hypoxic Training (IHT) Versus Hyperbaric Oxygen Therapy (HBOT) for Aerobic Performance

NCT05447416
View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT07732374Phase 2

Long-Term Outcomes Following HBOT

Recruiting
NCT07596641

Retrospective Analysis of CPET and Cognitive Tests of Healthy Individuals, Treated With 60 Treatment of HBOT

Not Yet Recruiting
NCT07560163

Triple-Modal Therapy in Early-Stage Femoral Head Osteonecrosis (TM-ONFH)

Completed
NCT07558928Not Applicable

Effect of Hyperoxygenated Environment on Maximal Muscle Strength

Recruiting
NCT05447416Not Applicable

Intermittent Hypoxic Training (IHT) Versus Hyperbaric Oxygen Therapy (HBOT) for Aerobic Performance

Recruiting
NCT06118138

Hyperbaric High Pressure Oxygen Therapy in Post-COVID Syndrome and ME/CFS

Completed
NCT07422168Not Applicable

Hyperbaric Oxygen Therapy for Treatment of Severe Radiation-Induced Complications

Completed
NCT07091266Not Applicable

SNM vs. HBOT for Refractory IC/BPS

Completed
NCT06284603Not Applicable

Effectiveness of Hyperbaric Oxygen Therapy in Adults

Completed
NCT04619719Not Applicable

Hyperbaric Oxygen for COVID-19 Patients With Moderate to Severe Hypoxemia

Terminated
NCT04472780Not Applicable

Hyperbaric Oxygen Treatment in Autism Spectrum Disorders

Unknown
NCT04332081Not Applicable

Hyperbaric Oxygen for COVID-19 Patients

Terminated
NCT03615755Not Applicable

Short Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine

Completed
NCT00715052Not Applicable

The Effect of Hyperbaric Oxygen Therapy on Patients Suffering From Neurologic Deficiency Due Traumatic Brain Injury

Completed
NCT00715897Not Applicable

Hyperbaric Oxygen Therapy Induced Neuroplasticity in Post Stroke Patients Suffering Chronic Neurological Deficiencies

Completed

All 15 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
15